All News
Advertisement
Advertisement
Advertisement
Advertisement
Jill Wechsler outlines how the new FDA commissioner tasked with curbing regulation, speeding approvals-and collecting more fees to do it.
Click the title above to open the Pharmaceutical Executive April 2017 issue in an interactive PDF format.
March 28, 2017
March 20, 2017
March 15, 2017
Click the title above to open the Pharmaceutical Executive March 2017 issue in an interactive PDF format.
February 28, 2017
February 28, 2017
February 23, 2017
February 22, 2017
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Single-Injection, Once-Monthly Maintenance Regimen for Lilly’s Omvoh in Ulcerative Colitis
2
Pharmaceutical Executive Daily: Organon CEO Kevin Ali Resigns
3
GSK Enters $745 Million Worldwide Exclusive License Agreement with Empirico for Clinical-Stage First-In-Class Oligonucleotide Candidate
4
FDA Expands Indication for Merck’s Winrevair in Pulmonary Arterial Hypertension
5
